Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism POU2F3 inhibitors(POU class 2 homeobox 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nematode Infections | Preclinical | US | 13 Jan 2014 |